These mechanisms include immune checkpoint modulation (e.g., PD‐1, CTLA‐4), secretion of immunosuppressive cytokines, and alteration of the tumor microenvironment (TME) to encourage immune tolerance.[27]. This evidence concerns the gene CTLA4 and neoplasm.